The clinical features of the AML patients in the CD56-high and CD56-low groups were analyzed, and, as a result, the two groups were found to have similar WBC counts and hemoglobin, in addition to the same composition in the FAB classification. Here, NCAM1 is linked to acute myeloid leukemia.